Press Releases

MINNEAPOLIS, March 5, 2020 /PRNewswire/ -- People with Parkinson's disease who participate in a special, non-contact boxing program may have better quality of life and be more likely to exercise than those who do not participate, according to a preliminary study released today that will be presented at the

BOSTON, March 5, 2020 /PRNewswire/ -- Interest and investment in healthcare AI/ML tools is booming with approxi­mately $4 billion in capital funding pouring into this healthcare sector in 2019. Such investment is spurring a vast array of AI/ML tools for providers, patients, and payers accelerating the possibilities for new solution

SUNNYVALE, Calif., March 5, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Michael Hoge, the company's new Senior Vice President, Global Operations. As a material inducement to Mr. Hoge joining the company, and in accordance with NASDA

NEW YORK, March 5, 2020 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) ("Actinium") today announced that the first patient has begun treatment in the third and final cohort of the Actimab-A CLAG-M combination trial. This Phase 1 trial is an investigator-initiated trial being conducted at the Medical College of

KIRKLAND, Wash., March 5, 2020 /PRNewswire/ -- Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure (HF), today announced the hiring of Gretchen Gary as Vice President of Global Therapy Development. Ms. Gary

NANJING, China, March 5, 2020 /PRNewswire/ -- In December 2019, the first case of coronavirus was discovered. The outbreak has affected many industries, especially the logistics industry. However, the challenges and opportun

CAMPBELL, Calif., March 5, 2020 /PRNewswire/ -- Supira Medical, formed by Shifamed as part of its medical innovation hub, announced today the closing of $35M in Series B financing. Officially closed on February 25, the financing was led by Cormorant Asset Management with participation from The Capital Part

LITTLE FALLS, N.J., March 5, 2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its second quarter ended January 31, 2020.

OLDWICK, N.J., March 5, 2020 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it will report its fourth quarter and full year 2019 financial results on Thursday, March 12, 2020.

CARMIEL, Israel, March 5, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today announced that it will release